Patents by Inventor DAVID H. HITT, II

DAVID H. HITT, II has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RESVERATROL MEDICATION FOR THE TREATMENT OF OCULAR PAIN AND METHOD OF USE THEREOF
    Publication number: 20210046018
    Abstract: The present disclosure provides ophthalmic compositions containing resveratrol. Also provided are methods of using ophthalmic resveratrol compositions to treat acute ocular pain, chronic ocular pain, dry eye disease, and/or photophobia.
    Type: Application
    Filed: August 13, 2020
    Publication date: February 18, 2021
    Applicants: TED'S BRAIN SCIENCE, INC., BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, OREGON HEALTH AND SCIENCE UNIVERSITY
    Inventors: SUE A. AICHER, GREGORY O. DUSSOR, THEODORE J. PRICE, DENNIS I. ROBBINS, DAVID H. HITT, II, DAVID H. HITT, III
  • AMPK agonist topical medication for the treatment of certain specific medical conditions, methods of use thereof and wound dressing employing the same
    Patent number: 10695287
    Abstract: A topical medication including a therapeutically effective amount of an AMPK (adenosine monophosphate-activated protein kinase) agonist for use in the treatment of one or more the human or animal medical conditions. The medical conditions include, but are not limited to: shingles (herpes zoster), post-herpetic neuralgia (PHN), gout, migraine, trigeminal neuralgia, Complex Regional Pain Syndrome (CRPS), diabetic neuropathy, peripheral neuropathy, rheumatoid arthritis, insect-related wheals, urushiol-related rash, psoriasis, herpes simplex, atopic dermatitis (eczema), contact dermatitis, allergic dermatitis, neurotrophic ulcers, first- and second-degree burns (e.g., sunburn and chemical), fibromyalgia, rubeola, and acne. Also disclosed are a method of employing the composition and a wound dressing incorporating a therapeutically effective amount of an AMPK agonist in combination with an antimicrobial agent.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: June 30, 2020
    Assignee: CerSci Therapeutics, Inc.
    Inventors: Dennis I. Robbins, David H. Hitt, II
  • AMPK AGONIST TOPICAL MEDICATION FOR THE TREATMENT OF CERTAIN SPECIFIC MEDICAL CONDITIONS, METHODS OF USE THEREOF AND WOUND DRESSING EMPLOYING THE SAME
    Publication number: 20180369133
    Abstract: A topical medication including a therapeutically effective amount of an AMPK (adenosine monophosphate-activated protein kinase) agonist for use in the treatment of one or more the human or animal medical conditions. The medical conditions include, but are not limited to: shingles (herpes zoster), post-herpetic neuralgia (PHN), gout, migraine, trigeminal neuralgia, Complex Regional Pain Syndrome (CRPS), diabetic neuropathy, peripheral neuropathy, rheumatoid arthritis, insect-related wheals, urushiol-related rash, psoriasis, herpes simplex, atopic dermatitis (eczema), contact dermatitis, allergic dermatitis, neurotrophic ulcers, first- and second-degree burns (e.g., sunburn and chemical), fibromyalgia, rubeola, and acne. Also disclosed are a method of employing the composition and a wound dressing incorporating a therapeutically effective amount of an AMPK agonist in combination with an antimicrobial agent.
    Type: Application
    Filed: August 31, 2018
    Publication date: December 27, 2018
    Inventors: DENNIS I. ROBBINS, DAVID H. HITT, II